Abstract:Lipid droplets (LDs) with own interface architecture not only play crucial roles in protecting cell from lipotoxicity and lipoapoptosis but also closely relate with many diseases such as fatty liver and diabetes. Thus, as one of important applied biomaterials, fluorescent probes with ultrahigh selectivity for in-situ and high-fidelity imaging LDs in living cells and tissues are critical to elucidate relevant physiological and pathological events as well as detect related diseases. However, available LDs probes only utilizing their waterless neutral cores but ignoring the unique phospholipid monolayer interfaces exhibit low selectivity. Particularly, current probes cannot discriminate neutral cores of LDs from intracellular other lipophilic microenvironments, so that extensively cloud-like background fluorescence diffusing in cytoplasm, which severely limited their applications. Herein, in order to design LDs probes with ultrahigh selectivity, the exceptionally interfacial architecture of LDs is considered adequately and thus an interface-targeting strategy is proposed for the first time. According to the novel strategy, we have developed two amphipathic fluorescent probes (N-Cy and N-Py) by introducing different cations into a lipophilic fluorophore (NBD). Consequently, their cationic moiety precisely locates the interfaces through electrostatic interaction and simultaneously NBD entirely embeds into the waterless core via hydrophobic interaction. Thus high-fidelity and background-free fluorescence imaging of LDs is expectably realized in living cells in-situ. Moreover, LDs in turbid tissues like skeletal muscle slices have been clearly imaged (up to 82 μm depth) in two-photon microscope. Importantly, using N-Cy, we not only intuitively monitored the variations of LDs in number, size and morphology, but also clearly revealed their abnormity in hepatic tissues resulted from fatty liver. Therefore, these unique probes provide excellent imaging tools for elucidating LDs-related physiological and pathological processes, and the interface-targeting strategy possesses universal significance for designing probes with ultrahigh selectivity.

A Lipid Droplets Specific Probe for Imaging of Atherosclerosis and Fibrocalcific Bicuspid Aortic Valves

Aggregation-induced Emission Fluorescent Probes for Lipid Droplets-Specific Bioimaging of Cells and Atherosclerosis Plaques

A Lipid Droplet-Specific Fluorescence Probe for Atherosclerotic Plaque Imaging.

A lipid activated color switchable probe for the imaging of diseased aortic valves

An Intelligent Probe with Dual-Emission in Water and Oil for Lipid Droplet Specific Imaging in Human Fibrocalcific Aortic Valvular Leaflet.

A turn-on fluorescent probe for lipid-targeting imaging in human arterial aneurysm and fibrocalcific stenotic aortic valve

Specific lipid droplet imaging of atherosclerotic plaques and fatty liver using an imidazole-based fluorescence probe

Interface-targeting strategy enables two-photon fluorescent lipid droplets probes for high-fidelity imaging turbid tissues and detecting fatty liver.

A pH-responsive nanoplatform with aggregation-induced emission features for lipid droplet imaging in atherosclerosis

Nitrobenzoxadiazole based lipid droplets specific probes for atherosclerosis imaging

A Lipid Activatable Fluorescence Probe for Atherosclerosis Imaging

Lipid Droplets Targeting Fluorescent Probes with AIE Properties for the Diagnosis of Fatty Liver Tissue

An AIEgen-based Fluorescent Probe for Highly Selective and Specific Imaging of Lipid Droplets in L02 and HepG2 Cells

Aggregation-induced emission fluorogenic probes for wash-free imaging of lipid droplets in living cells

Red fluorescent AIE bioprobes with a large Stokes shift for droplet-specific imaging and fatty liver diagnosis

An Advanced Organic Molecular Probe for Multimodal Fluorescence Imaging of Cellular Lipid Droplets

Dual-response Fluorescent Probe for Lipid Droplets and Hypochlorous Acid and Imaging Study in Inflammation and Atheromatous Plaques

Lipid droplets-specific fluorescent probe for wash-free imaging and in vivo diagnosis of non-alcoholic fatty liver disease

Light-up lipid droplets for the visualization of lipophagy and atherosclerosis by coumarin-derived bioprobe

Recent Advances in Lipid-responsive Probes in the Imaging and Treatment of Atherosclerosis

Lipid droplet-specific near-infrared fluorescent probe for discriminating cancer and normal cells and diagnosing fatty liver